Previous 10 | Next 10 |
BioLife Solutions press release ( NASDAQ: BLFS ): Q3 GAAP EPS of -$0.23 misses by $0.06 . Adjusted net loss (non-GAAP) for the third quarter of 2022 was $6.6 million compared with adjusted net loss of $8.3 million for the third quarter of 2021. Revenue of $40.7M (+...
BioLife Solutions Reports Third Quarter 2022 Financial Results PR Newswire Record revenue of $40.7 million increased 21% over Q3 2021; biopreservation media revenue growth of 50%, validating leading position as a critical cell and gene therapies tool supplier ...
BioLife Solutions to Report Third Quarter 2022 Financial Results and Provide Business Update on November 9, 2022 PR Newswire BOTHELL, Wash. , Nov. 2, 2022 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bi...
Summary BioLife recently formed a strategic partnership with CSafe to expand its service repertoire for its customers. The latest quarter reported extremely strong growth across all operations. While the company seemingly fixed most issues, the former COO (Rod de Greef) recent...
CSafe and BioLife Solutions, Inc. announce partnership to expand supply chain solutions for the cell and gene therapy market Canada NewsWire CSafe joins BioLife's global partner network of cold chain solution providers using the evo ® cold chain management p...
BioLife Solutions ( NASDAQ: BLFS ) said on Monday its Chief Operating Officer Roderick de Greef will retire in January and join the board of directors. Geraint Phillips will assume responsibilities in January as newly promoted Senior Vice President of Gl...
BioLife Solutions Announces COO to Retire and Join Board of Directors PR Newswire Roderick de Greef retirement planned for January 2023 with appointment to BioLife Board of Directors Geraint Phillips to assume responsibilities in January 2023 ...
Summary As a small logistics operator servicing other celllular therapy innovators, Cryoport is powered by the prudent merger/acquisition growth approach. Regardless of the bear market, Cryoport has been enjoying huge topline growth from successful acquisitions. Asides from bu...
BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors PR Newswire Industry veteran brings extensive technical operations scale-up experience and extreme fluency in cell therapy tools and services selection process BOTHEL...
BioLife Solutions, Inc. (BLFS) Q2 2022 Earnings Conference Call August 09, 2022 04:30 PM ET Company Participants Troy Wichterman - Chief Financial Officer Mike Rice - Chairman and Chief Executive Officer Rod de Greef - President and Chief Operating Officer ...
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 PR Newswire BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction...
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...